4 March 2008
Annual report 2007
22 April 2008
Annual General Meeting
7 May 2008
Interim report for the first quarter of 2008
13 August 2008
Interim report for the second quarter of 2008
12 November 2008
Interim report for the third quarter of 2008
Lundbeck contacts
Investors: Media:
Jacob Tolstrup Anders Schroll
Director, Corporate Reporting Head of Communication
+45 36 43 30 79 +45 36 43 20 81
Palle Holm Olesen
Head of Investor Relations
+45 36 43 24 26
________________________
Stock Exchange Release No 316 - 20 December 2007
About Lundbeck
H. Lundbeck A/S is an international pharmaceutical company engaged in
the research and development, production, marketing and sale of drugs
for the treatment of psychiatric and neurological disorders. In 2006,
the company's revenue was DKK 9.2 billion (approximately EUR 1.2
billion or USD 1.6 billion). The number of employees is approximately
5,300 globally. For further information, please visit
www.lundbeck.com
